Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MHLW To Expand Drug Application Consultation Services July 1, But With A Price Tag For Industry

This article was originally published in PharmAsia News

Executive Summary

TOKYO - Japan's Ministry of Health, Labor and Welfare established a panel to improve the Pharmaceuticals and Medical Devices Agency's consultation services as one measure to eliminate Japan's drug and medical device lag, and the agency is expected to expand the range and number of consultations starting this year
Advertisement

Related Content

Eisai's Venture-Like R&D Starts To Produce Results, And Shorter Development Timelines
Eisai's Venture-Like R&D Starts To Produce Results, And Shorter Development Timelines
Japan's Improved Clinical Trial Requirements Bring Positive Impact To China, Korea Development
Japan's Improved Clinical Trial Requirements Bring Positive Impact To China, Korea Development
Advertisement
UsernamePublicRestriction

Register

SC078405

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel